Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 401–450 of 33433
On July 10, 2026, each of William M. Goodyear and Mark McGowan submitted their resignations as directors of Enova International, Inc. (the “Company”), effective immediately.
On July 10, 2026, each of William M. Goodyear and Mark McGowan submitted their resignations as directors of Enova International, Inc. (the “Company”), effective immediately.
On July 7, 2026, James J. Ferguson III, Chief Medical Officer of Cadrenal Therapeutics, Inc. (the “Company”), advised the Board of Directors of the Company of his decision to resign from his position as Chief Medical Officer of the Company, effective July 31, 2026 (the “Separation Date”).
On July 6, 2026, George Holding notified Trump Media & Technology Group Corp. (the “Company”) of his resignation from its Board of Directors (the “Board”), and the committees on which he served, effective immediately.
Harriette Lo resigned from her role as the Registrant’s Co-Chairwoman, director
Yee Wei Tan resigned from his role as the Registrant’s director and Chief Financial Officer.
Han Wei Wang resigned from his role as the Registrant’s director and Chief Executive Officer.
On July 1, 2026, AppTech Payments Corp. (the “Company”) released Thomas J. DeRosa from his roles as President and Chief Executive Officer of the Company, effective immediately.
On July 7, 2026, Park Aerospace Corp. terminated the employment of Cory Nickel, Senior Vice President and General Manager of the Company, effective immediately.
On July 8, 2026, Nathaniel Fick resigned from his role as a Class III director of the Board, effective July 8, 2026, to accept an appointment as preferred stock director of the Board.
On July 8, 2026, Greg Nixon resigned from his role as a preferred stock director of the Board of Directors (the “Board”) of Eos Energy Enterprises, Inc. (the “Company”), effective July 8, 2026, to devote more time to other business ventures.
On July 2, 2026, Austin Kaplicer, Chief Accounting Officer and principal accounting officer of Angi Inc. (the “Company”), notified the Company of his decision to resign, effective as of August 6, 2026.
Effective July 9, 2026, the employment of Mr. Kirk D. Jensen with the registrant and its wholly owned subsidiary First Interstate Bank as Executive Vice President and General Counsel/Corporate Secretary was terminated involuntarily and without cause
On July 8, 2026, Paul Grewal notified Coinbase Global, Inc. (“Coinbase” or the “Company”) of his intention to step down as Chief Legal Officer and Secretary of Coinbase, effective July 31, 2026.
On July 7, 2026, Daniel R. Kozlowski notified the Board of Directors (the “ Board ”) of the Registrant of his resignation from the Board, effective immediately.
On July 2, 2026, Matt Link notified FibroBiologics, Inc. (the “Company”) that he was resigning from the Board of Directors (the “Board”), effective as of July 2, 2026.
On July 2, 2026, Mike Schmidt notified Nixxy, Inc. (the "Company") of his decision to resign as Chief Executive Officer of the Company and as a member of the Company's Board of Directors (the "Board"), effective immediately.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
Peter Ort resigned as Chief Executive Officer and Co-Chairman
Jeff Tuder resigned as Chief Financial Officer and Co-Chairman
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
Jane Novak ceased to be Chief Financial Officer
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
Brandon G. Lutnick ceased to be Chairman and Chief Executive Officer
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
On July 1, 2026, Karen Ferrante, M.D. provided notice to the board of directors (the “Board”) of MacroGenics, Inc. (the “Company”) of her decision to resign from the Board, effective September 1, 2026.
Effective July 7, 2026, John Williams, Jr., a member of the Board of Directors (the “Board”) of Old Second Bancorp, Inc. (the “Company”), resigned from the Board.
On June 30, 2026, Renger van den Heuvel, Crisp Momentum Inc.’s (the “Company”) Chief Executive Officer, principal financial officer, principal accounting officer, and a member of the Company’s Board of Directors (the “Board”), resigned from his officer and director positions with the Company.
On July 2, 2026, Chris Sambar, the Chief Operating Officer of Public Storage (the “Company”), resigned effective at the end of July to join T-Mobile as Chief Enterprise Officer.
Mr. Lowenthal was notified on July 6, 2026 that his employment was being terminated without cause, effective immediately.
On June 30, 2026, Steven Dassing resigned from his position as Vice President, Corporate Controller and Principal Accounting Officer of Quaker Chemical Corporation (“Quaker Houghton” or the “Company”) effective July 22, 2026.
Michael Buhle ceased serving as the Company’s Chief Executive Officer effective June 17, 2026
After over two decades in various leadership positions with the Company, Michael J. Katz, the Company’s Chief Business and Product Officer, has decided to step away from his position at the Company effective July 8, 2026, but he will remain with the Company as a strategic advisor through December 2026.
On July 2, 2026, Jeffrey Rhodes notified the LifeStance Health Group, Inc. (the “Company”) board of directors (the “Board”) of his resignation from the Board and all of its committees, effective immediately.
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Effective July 7, 2026, Ms. Coco Kou, Chief Financial Officer of the Company resigned from her position with the Company, effective immediately.
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
On July 2, 2026, Carson Heagen, the Chief Operating Officer of Expion360 Inc. (the “Company”), notified the board of directors of the Company that he is resigning from his role as Chief Operating Officer, effective August 1, 2026, due to personal reasons.
On July 6, 2026, Shawn Morris resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Compliance Committee of the Board, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.